AstraZeneca has added to its oncology pipeline by licensing a small-molecule KRAS inhibitor from Chinese biotech Usynova for $24 million upfront. The compound – called UA022 – targets the ...
What even people inside tennis did not know until her 2017 book, Unbreakable, written with Jessica Halloran, was how much that ratbag father, Damir Dokic, was controlling and abusing his daughter.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback